JPMorgan Chase & Co. Sells 576,747 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)

JPMorgan Chase & Co. lowered its stake in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) by 97.4% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,305 shares of the company’s stock after selling 576,747 shares during the quarter. JPMorgan Chase & Co.’s holdings in Ginkgo Bioworks were worth $125,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DNA. Algert Global LLC bought a new stake in shares of Ginkgo Bioworks during the 2nd quarter worth $36,000. Mackenzie Financial Corp acquired a new position in Ginkgo Bioworks during the 2nd quarter worth $251,000. Point72 Asia Singapore Pte. Ltd. grew its position in shares of Ginkgo Bioworks by 644.5% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 32,319 shares of the company’s stock valued at $263,000 after purchasing an additional 27,978 shares during the last quarter. Verition Fund Management LLC bought a new position in shares of Ginkgo Bioworks in the third quarter worth about $792,000. Finally, Forbes J M & Co. LLP acquired a new position in shares of Ginkgo Bioworks during the 3rd quarter worth about $1,019,000. Institutional investors and hedge funds own 78.63% of the company’s stock.

Ginkgo Bioworks Stock Performance

Shares of NYSE:DNA opened at $13.35 on Monday. The firm’s 50 day simple moving average is $10.35. The company has a market cap of $767.07 million, a P/E ratio of -1.02 and a beta of 1.09. Ginkgo Bioworks Holdings, Inc. has a twelve month low of $5.26 and a twelve month high of $64.40.

Ginkgo Bioworks Company Profile

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.